遺伝子パネルの市場規模、シェア、動向分析レポート：製品・サービス別（テストキット、検査サービス）、技術別、デザイン別、用途別、最終用途別、地域別、セグメント別予測、2022年～2030年

遺伝子パネル市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界の遺伝子パネル市場規模は、2022年から2030年まで15.52%のCAGRで拡大し、2030年には27億2000万米ドルに達すると予測されています。先天性障害の増加や、世界のがん患者数の未曾有の増加が、市場を牽引すると予想されています。染色体異常の早期診断により、タイムリーな予後予測や治療措置が可能となるため、症状を遅らせたり、生活の質を向上させたりすることができます。

さらに、遺伝性の理解や遺伝子スクリーニング、個別化医療、リスク分析、予後予測などのニーズの高まりが、市場を牽引すると予想されます。疾患の遺伝的素因を理解するためには、特定の遺伝子群の配列決定と解析が必要です。パネルは、疾患の原因となることが知られている特定の遺伝子の配列を決定するのに役立ちます。特定の疾患に対してあらかじめデザインされたパネルが多数あり、またカスタマイズも可能です。また、幅広い遺伝子疾患を効率的に診断するために、新しい遺伝子パネルを開発するための研究努力も続けられています。

例えば、INVIEW Liquid Biopsy Onco-profilingは、血液のような液体生検サンプルを用いて検査するための包括的ながん遺伝子パネルです。また、特定の要件に基づいてカスタマイズ可能な遺伝子パネルもあります。例えば、QIAseqマルチモーダルカスタムパネルは、1つのサンプル入力からバリアントDNA、RNA融合、遺伝子発現パターンをプロファイルすることができるカスタマイズ可能な遺伝子パネルです。

COVID-19の大流行により、遺伝カウンセリングや遺伝学的検査サービスを含む効果的なヘルスケアサービスの提供は著しく阻害されています。少なくとも着床前スクリーニングについては、遺伝子検査の再着手を確実にするための取り組みが米国全土で行われています。しかし、がんに対する遺伝子スクリーニングの強化は、世界中のがん学会のミッションの一部にもなっています。

さらに、多くの研究者や臨床医は、遺伝性疾患による死亡率を下げるために、遺伝子スクリーニングの実施が強く必要と考えており、そのため予測期間中に遺伝子パネルの需要が増加すると思われます。例えば、米国で生まれた子供はすべて、特定の遺伝子、内分泌、代謝、聴覚、先天性心疾患について、血液サンプルを用いた強制的なスクリーニング検査を受けています。

遺伝子パネル市場レポートハイライト

製品・サービス別では、検査キットが臨床医、研究者、健常者に提供できる実用的な利点から、検査キット分野が2021年に最大のシェアを占めました。最近では、すぐに使えるキットや自己投与可能な診断キットがますますトレンドになっている

手法別では、ハイブリダイゼーションに基づく手法が、高価で時間がかかるもの、結果の信頼性から成長段階にあります。遺伝子パネルは通常、複数の遺伝子を解析するために設計されるが、ハイブリダイゼーション技術はこの遺伝子パネル検査のコンセプトに適しています。

デザイン別では、2021年にプレデザイニング遺伝子パネルが市場を独占しました。これは、診断の有用性において、カスタマイズ可能な遺伝子パネルよりもデザイン済みの遺伝子パネルが好まれるためで、デザイン済みのパネルは、結果の信頼性についての調査によって裏付けられているためである

用途別では、がん患者数の増加や各国におけるがん検診の推奨の増加により、がんリスク評価分野が予測期間中に大きく成長すると予想される

遺伝子スクリーニングや早期がんスクリーニングの需要増加、主要プレイヤーの存在、がん罹患率の上昇、新生児スクリーニングの推奨の高まりにより、2021年の世界市場は北米が優位を占める

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • セグメントの範囲
  • 地域範囲
• 調査手法
  • 情報調達
  • 情報分析
  • 市場形成
  • 検証と公開
• 情報調達
  • 購入したデータベース
  • GVRの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査内容
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析
    • アプローチ：商品フローアプローチ
• 二次情報一覧
• 略語一覧
• 目的

第2章 エグゼクティブサマリー

• 市場の見通し
• 市場概要

第3章 遺伝子パネル市場：変数、動向、および範囲

• 遺伝子パネル市場の変数、動向、および範囲
• 市場促進要因分析
  • 遺伝性疾患の増加する発生率
  • 個別化医療の必要性の高まり
  • 高い特異性と信頼性
  • 市場抑制要因分析
  • 法外なコスト要因
  • 限られた理解
  • 市場機会分析
  • 市場の脅威分析
• 業界分析：ポーターズ
• SWOT分析：要因別（政治と法律、経済、技術）

第4章 遺伝子パネル市場：セグメント分析、製品およびサービス別、2018年-2030年（100万米ドル）

• 遺伝子パネル市場：製品とサービスの変動分析
  • テストキット
  • 試験サービス

第5章 遺伝子パネル市場：セグメント分析、技術別、2018年から2030年（100万米ドル）

• 遺伝子パネル市場：技術変動分析
  • アンプリコンベースのアプローチ
  • ハイブリダイゼーションに基づくアプローチ

第6章 遺伝子パネル市場：セグメント分析、2018年から2030年までの設計別（100万米ドル）

• デザイン済み遺伝子パネル
• カスタマイズされた遺伝子パネル

第7章 遺伝子パネル市場：アプリケーション別セグメント分析、2018年から2030年（100万米ドル）

• がんリスク評価
  • 症候群特有のがんリスク評価
  • 高浸透率がんリスク評価
  • 高浸透度および中等度浸透度のがんリスク評価
  • 包括的ながんリスク評価
• 先天性疾患の診断
• 薬理遺伝学
• その他のアプリケーション

第8章 遺伝子パネル市場：セグメント分析、最終用途別、2018年から2030年（100万米ドル）

• 調査機関および学術機関
• 病院および診断検査室
• 製薬およびバイオテクノロジー企業

第9章 遺伝子パネル市場：地域別ビジネス分析

• 地域市場のスナップショット
• 市場規模、予測、トレンド分析、2021年から2030年
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ロシア
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東およびアフリカ（MEA）
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 遺伝子パネル市場-競合分析

• 最近の動向と影響の解釈：主要な市場参入企業別
  • アンソフマトリックス
• 会社の分類
  • イノベーター
  • 市場のリーダー
  • 主要顧客
• Synergy Interpretation：Major Deals &Strategic Alliances
  • 新製品の発売
  • 取得
  • 拡張
  • パートナーシップ
  • マーケティングとプロモーション
• 企業プロファイル
  • AGILENT TECHNOLOGIES INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • ILLUMINA INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • QIAGEN INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • EUROFINS GENOMICS
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • INIVATA
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • SINGLERA GENOMICS
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • GENECAST
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • FOUNDATION MEDICINE INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • 23ANDME, INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • FREENOME
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • MYRIAD GENETICS
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • CEPHEID（DANAHER）
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • BIORAD LABORATORIES INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • BGI GENOMICS INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • INVITAE CORPORATION
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • CENTOGENE NV
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • GENE DX, LLC（SEMA4）
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ

List of Tables

• 1. List of Secondary Sources
• 2. List of Abbreviations
• 3. Global Gene Panel Market, by Region, 2018 - 2030 (USD Million)
• 4. Global Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 5. Global Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 6. Global Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 7. Global Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 8. Global Gene Panel Market, by End-Use, 2018 - 2030 (USD Million)
• 9. Global Gene Panel Market, by Region, 2018 - 2030 (USD Million)
• 10. North America Gene Panel Market, by Country, 2018 - 2030 (USD Million)
• 11. North America Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 12. North America Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 13. North America Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 14. North America Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 15. North America Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 16. U.S. Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 17. U.S. Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 18. U.S. Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 19. U.S. Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 20. U.S. Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 21. Canada Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 22. Canada Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 23. Canada Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 24. Canada Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 25. Canada Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 26. Europe Gene Panel Market, by Country, 2018 - 2030 (USD Million)
• 27. Europe Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 28. Europe Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 29. Europe Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 30. Europe Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 31. Europe Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 32. Germany Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 33. Germany Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 34. Germany Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 35. Germany Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 36. Germany Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 37. U.K. Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 38. U.K. Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 39. U.K. Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 40. U.K. Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 41. U.K. Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 42. France Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 43. France Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 44. France Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 45. France Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 46. France Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 47. Italy Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 48. Italy Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 49. Italy Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 50. Italy Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 51. Italy Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 52. Spain Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 53. Spain Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 54. Spain Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 55. Spain Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 56. Spain Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 57. Russia Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 58. Russia Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 59. Russia Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 60. Russia Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 61. Russia Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 62. Asia Pacific Gene Panel Market, by Country, 2018 - 2030 (USD Million)
• 63. Asia Pacific Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 64. Asia Pacific Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 65. Asia Pacific Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 66. Asia Pacific Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 67. Asia Pacific Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 68. China Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 69. China Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 70. China Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 71. China Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 72. China Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 73. Japan Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 74. Japan Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 75. Japan Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 76. Japan Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 77. Japan Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 78. India Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 79. India Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 80. India Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 81. India Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 82. India Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 83. South Korea Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 84. South Korea Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 85. South Korea Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 86. South Korea Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 87. South Korea Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 88. Australia Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 89. Australia Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 90. Australia Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 91. Australia Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 92. Australia Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 93. Latin America Gene Panel Market, by Country, 2018 - 2030 (USD Million)
• 94. Latin America Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 95. Latin America Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 96. Latin America Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 97. Latin America Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 98. Latin America Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 99. Brazil Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 100. Brazil Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 101. Brazil Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 102. Brazil Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 103. Brazil Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 104. Mexico Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 105. Mexico Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 106. Mexico Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 107. Mexico Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 108. Mexico Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 109. Argentina Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 110. Argentina Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 111. Argentina Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 112. Argentina Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 113. Argentina Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 114. Middle East & Africa Gene Panel Market, by Country, 2018 - 2030 (USD Million)
• 115. Middle East & Africa Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 116. Middle East & Africa Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 117. Middle East & Africa Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 118. Middle East & Africa Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 119. Middle East & Africa Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 120. South Africa Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 121. South Africa Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 122. South Africa Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 123. South Africa Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 124. South Africa Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 125. Saudi Arabia Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 126. Saudi Arabia Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 127. Saudi Arabia Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 128. Saudi Arabia Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 129. Saudi Arabia Gene Panel Market, by End-use, 2018 - 2030 (USD Million)
• 130. UAE Gene Panel Market, by Product & Services, 2018 - 2030 (USD Million)
• 131. UAE Gene Panel Market, by Technique, 2018 - 2030 (USD Million)
• 132. UAE Gene Panel Market, by Design, 2018 - 2030 (USD Million)
• 133. UAE Gene Panel Market, by Application, 2018 - 2030 (USD Million)
• 134. UAE Gene Panel Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

• 1. Gene panel market segmentation
• 2. Market research process
• 3. Information procurement
• 4. Primary research pattern
• 5. Market research approaches
• 6. Value-chain-based sizing & forecasting
• 7. QFD modeling for market share assessment
• 8. Market formulation & validation
• 9. Market snapshot 2021 (USD Million)
• 10. Market Trends & Outlook
• 11. Market Driver analysis
• 12. Porter's Five Forces Analysis
• 13. SWOT analysis, by factor (political & legal, economic, and technological)
• 14. Gene Panel Market: Product & Services Outlook Key Takeaways
• 15. Global gene panel kits market, 2018 - 2030 (USD Million)
• 16. Global gene panel services market, 2018 - 2030 (USD Million)
• 17. Gene Panel Market: Technique Outlook Key Takeaways
• 18. Global amplicon-based approach gene panel market, 2018 - 2030 (USD Million)
• 19. Global hybridization based approach gene panel market, 2018 - 2030 (USD Million)
• 20. Gene Panel Market: Design Outlook Key Takeaways
• 21. Global predesigned gene panel market, 2018 - 2030 (USD Million)
• 22. Global customized gene panel market, 2018 - 2030 (USD Million)
• 23. Gene panel market: Application Outlook Key Takeaways
• 24. Global cancer assessment-based gene panel market, 2018-2030 (USD Million)
• 25. Global syndrome specific cancer assessment based gene panel market, 2018 - 2030 (USD Million)
• 26. Global high penetrance cancer assessment based gene panel market, 2018 - 2030 (USD Million)
• 27. Global high & moderate penetrance cancer assessment based gene panel market, 2018 - 2030 (USD Million)
• 28. Global comprehensive cancer risk assessment based gene panel market, 2018 - 2030 (USD Million)
• 29. Global diagnosis of congenital diseases based gene panel market, 2018 - 2030 (USD Million)
• 30. Global pharmacogenetics based gene panel market, 2018 - 2030 (USD Million)
• 31. Global other applications based gene panel market, 2018 - 2030 (USD Million)
• 32. Gene panel market: End-use Outlook Key Takeaways
• 33. Global research & academic institutes based gene panel market, 2018 - 2030 (USD Million)
• 34. Global hospital & diagnostic laboratories based gene panel market, 2018 - 2030 (USD Million)
• 35. Global pharmaceutical & biotechnology companies based Gene Panel Market, 2018 - 2030 (USD Million)
• 36. Regional Market Place: Key Takeaways
• 37. North America gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 38. U.S. gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 39. Canada gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 40. Europe gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 41. U.K. gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 42. Germany gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 43. France gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 44. Italy gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 45. Spain gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 46. Russia gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 47. Asia Pacific gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 48. Japan gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 49. China gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 50. India gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 51. South Korea gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 52. Australia gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 53. Latin America gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 54. Brazil gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 55. Mexico gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 56. Argentina gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 57. MEA gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 58. South Africa gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 59. Saudi Arabia gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 60. UAE gene panel market estimates and forecast, 2018 - 2030 (USD Million)
• 61. Ansoff Matrix

Gene Panel Market Growth & Trends:

The global gene panel market size is expected to reach USD 2.72 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 15.52% from 2022 to 2030. A rise in the number of congenital disorders, coupled with an unprecedented increase in the number of cancer cases across the globe, is anticipated to drive the market. Early diagnosis of chromosomal disorders enables timely prognosis and therapeutic steps to be taken so as to retard the symptoms and improve the quality of life.

Furthermore, an increase in hereditary level understanding and a rise in the need for genetic screening, personalized medicine, risk analysis, and prognostics are anticipated to drive the market. A specific group of genes needs to be sequenced and analyzed to understand the genetic predisposition of a disease condition. The panels help in sequencing specific genes that are known to be causative of the disease condition. There are many predesigned panels for particular disease conditions along with options for customization. There also have been consistent research efforts to devise novel gene panels to efficiently diagnose a wide spectrum of genetic disorders.

For instance, INVIEW Liquid Biopsy Onco-profiling is an all-inclusive comprehensive cancer gene panel for examination using liquid biopsy samples like blood. Customizable gene panels are also available that can be customized based on specific requirements. For instance, QIAseq multimodal custom panel is a customizable gene panel that is able to profile variant DNA, RNA fusion, and gene expression patterns from a single sample input.

The COVID-19 pandemic has significantly disrupted the delivery of effective healthcare services, including genetic counseling and genetic testing services. There are efforts across the U.S. to ensure re-igniting genetic testing, at least for pre-implantation screening. However, the ramping up of genetic screening for cancer has also become a part of the mission of cancer societies across the globe.

Moreover, many researchers and clinicians believe that there is a strong necessity for the enforcement of genetic screening procedures to bring down the mortality rate due to genetic disorders, and therefore there will be a rise in the demand for gene panels during the forecast period. For instance, all those born in the U.S. are compulsorily screened using a blood sample for certain genetic, endocrine, metabolic, hearing, and critical congenital heart disorders.

Gene Panel Market Report Highlights:

• By products & services, the test kits segment held the largest share in 2021 due to the utilitarian benefits that a test kit could offer to clinicians, researchers, and the normal population. Ready-to-use kits and self-administrable diagnostic kits are increasingly trending these days

• By technique, the hybridization-based approach is in the growth phase due to the reliability of outcomes, though the technique is expensive and time-consuming. Gene panels are usually designed for the analysis of several genes and the hybridization technique is conducive to this concept of gene panel testing

• By design, predesigned gene panels dominated the market in 2021. This is because predesigned gene panels are preferred over customizable gene panels for diagnostic utility because predesigned panels are backed by research for outcome reliability

• By application, the cancer risk assessment segment is expected to grow lucratively during the forecast period due to a rise in the number of cancer cases and increased recommendations for cancer screening across different countries

• North America dominated the global market in 2021 owing to the increasing demand for genetic screening and early cancer screening, the presence of key players, the rising prevalence of cancer, and rising recommendations for newborn screening

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Segment Scope
  • 1.1.2 Regional Scope
  • 1.1.3 Estimates and Forecast Timeline
• 1.2 Research Methodology
  • 1.2.1 Information Procurement
  • 1.2.2 Information Analysis
  • 1.2.3 Market Formulation
  • 1.2.4 Validation & Publishing
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 GVR'S Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details of Primary Research
• 1.4 Information or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach: Commodity Flow Approach
• 1.7 List of Secondary Sources
• 1.8 List of Abbreviations
• 1.9 Objectives
  • 1.9.1 Objective 1
  • 1.9.2 Objective 2
  • 1.9.3 Objective 3
  • 1.9.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Market Summary

Chapter 3 Gene Panel Market Variables, Trends, & Scope

• 3.1 Gene Panel Market Variables, Trends, and Scope
• 3.2 Market Driver Analysis
  • 3.2.1 Growing Incidence of Genetic Disorders
  • 3.2.2 Rising Need for Personalized Medicine
  • 3.2.3 High Specificity and Reliability
  • 3.2.4 Market Restraint Analysis
  • 3.2.5 Exorbitant Cost Factor
  • 3.2.6 Limited Understanding
  • 3.2.7 Market Opportunity Analysis
  • 3.2.8 Market Threat Analysis
• 3.3 Industry Analysis - Porter's
• 3.4 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)

Chapter 4 Gene Panel Market - Segment Analysis, by Product & Services, 2018 - 2030 (USD Million)

• 4.1 Gene Panel Market: Product & Services Movement Analysis
  • 4.1.1 Test Kits
    • 4.1.1.1 Global test kits based gene panel market, 2018 - 2030 (USD Million)
  • 4.1.2 Testing Services
    • 4.1.2.1 Global testing services based gene panel Market, 2018 - 2030 (USD Million)

Chapter 5 Gene Panel Market - Segment Analysis, by Technique, 2018 - 2030 (USD Million)

• 5.1 Gene Panel Market: Technique Movement Analysis
  • 5.1.1 Amplicon Based Approach
    • 5.1.1.1 Global amplicon based approach gene panel market, 2018 - 2030 (USD Million)
  • 5.1.2 Hybridization Based Approach
    • 5.1.2.1 Global hybridization based approach gene panel market, 2018 - 2030 (USD Million)

Chapter 6 Gene Panel Market - Segment Analysis, by Design, 2018 - 2030 (USD Million)

• 6.1 Predesigned Gene Panel
  • 6.1.1 Global predesigned gene panel market, 2018 - 2030 (USD Million)
• 6.2 Customized Gene Panel
  • 6.2.1 Global customized gene panel market, 2018 - 2030 (USD Million)

Chapter 7 Gene Panel Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)

• 7.1 Cancer Risk Assessment
  • 7.1.1 Global cancer risk assessment based gene panel market, 2018 - 2030 (USD Million)
  • 7.1.2 Syndrome Specific Cancer Risk Assessment
    • 7.1.2.1 Global syndrome specific cancer risk assessment based gene panel market, 2018 - 2030 (USD Million)
  • 7.1.3 High Penetrance Cancer Risk Assessment
    • 7.1.3.1 Global high penetrance cancer risk assessment based gene panel market, 2018 - 2030 (USD Million)
  • 7.1.4 High & Moderate Penetrance Cancer Risk Assessment
    • 7.1.4.1 Global high & moderate penetrance cancer risk assessment based gene panel market, 2018 - 2030 (USD Million)
  • 7.1.5 Comprehensive Cancer Risk Assessment
    • 7.1.5.1 Global comprehensive cancer risk assessment based gene panel market, 2018 - 2030 (USD Million)
• 7.2 Diagnosis of Congenital Diseases
  • 7.2.1 Global diagnosis of congenital diseases based gene panel market, 2018 - 2030 (USD Million)
• 7.3 Pharmacogenetics
  • 7.3.1 Global pharmacogenetics based gene panel market, 2018 - 2030 (USD Million)
• 7.4 Other Applications
  • 7.4.1 Global other applications based gene panel market, 2018 - 2030 (USD Million)

Chapter 8 Gene Panel Market - Segment Analysis, by End-Use, 2018 - 2030 (USD Million)

• 8.1 Research and Academic Institutes
  • 8.1.1 Global research and academic institutes based gene panel market, 2018 - 2030 (USD Million)
• 8.2 Hospital and Diagnostic Laboratories
  • 8.2.1 Global hospital and diagnostic laboratories market, 2018 - 2030 (USD Million)
• 8.3 Pharmaceutical and Biotechnology Companies
  • 8.3.1 Global pharmaceutical and biotechnology companies based gene panel market, 2018 - 2030 (USD Million)

Chapter 9 Gene Panel Market -Regional Business Analysis

• 9.1 Regional Market Snapshot
• 9.2 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
• 9.3 North America
  • 9.3.1 North America gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.3.2 U.S.
    • 9.3.2.1 U.S. gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.3.3 Canada
    • 9.3.3.1 Canada gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
• 9.4 Europe
  • 9.4.1 Europe gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.4.2 U.K.
    • 9.4.2.1 U.K. gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.4.3 Germany
    • 9.4.3.1 Germany gene panels market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.4.4 France
    • 9.4.4.1 France gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.4.5 Italy
    • 9.4.5.1 Italy gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.4.6 Spain
    • 9.4.6.1 Spain gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.4.7 Russia
    • 9.4.7.1 Russia gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
• 9.5 Asia Pacific
  • 9.5.1 Asia Pacific gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.5.2 Japan
    • 9.5.2.1 Japan gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.5.3 China
    • 9.5.3.1 China gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.5.4 India
    • 9.5.4.1 India gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.5.5 South Korea
    • 9.5.5.1 South Korea gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.5.6 Australia
    • 9.5.6.1 Australia gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
• 9.6 Latin America
  • 9.6.1 Latin America gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.6.2 Brazil
    • 9.6.2.1 Brazil gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.6.3 Mexico
    • 9.6.3.1 Mexico gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.6.4 Argentina
    • 9.6.4.1 Argentina gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
• 9.7 Middle East & Africa (MEA)
  • 9.7.1 MEA gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.7.2 South Africa
    • 9.7.2.1 South Africa gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.7.3 Saudi Arabia
    • 9.7.3.1 Saudi Arabia gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.7.4 UAE
    • 9.7.4.1 UAE gene panel market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 10 Gene Panel Market - Competitive Analysis

• 10.1 Recent Developments & Impact Interpretation, by Key Market Participants
  • 10.1.1 ANSOFF MATRIX
• 10.2 Company Categorization
  • 10.2.1 Innovators
  • 10.2.2 Market Leaders
  • 10.2.3 Key Customers
• 10.3 Synergy Interpretation: Major Deals & Strategic Alliances
  • 10.3.1 New Product Launch
  • 10.3.2 Acquisition
  • 10.3.3 Expansion
  • 10.3.4 Partnerships
  • 10.3.5 Marketing & Promotions
• 10.4 Company Profiles
  • 10.4.1 AGILENT TECHNOLOGIES INC.
    • 10.4.1.1 Company overview
    • 10.4.1.2 Financial performance
    • 10.4.1.3 Product benchmarking
    • 10.4.1.4 Strategic initiatives
  • 10.4.2 ILLUMINA INC.
    • 10.4.2.1 Company overview
    • 10.4.2.2 Financial performance
    • 10.4.2.3 Product benchmarking
    • 10.4.2.4 Strategic initiatives
  • 10.4.3 QIAGEN INC.
    • 10.4.3.1 Company overview
    • 10.4.3.2 Financial performance
    • 10.4.3.3 Product benchmarking
    • 10.4.3.4 Strategic initiatives
  • 10.4.4 EUROFINS GENOMICS
    • 10.4.4.1 Company overview
    • 10.4.4.2 Financial performance
    • 10.4.4.3 Product benchmarking
    • 10.4.4.4 Strategic initiatives
  • 10.4.5 INIVATA
    • 10.4.5.1 Company overview
    • 10.4.5.2 Financial performance
    • 10.4.5.3 Product benchmarking
    • 10.4.5.4 Strategic initiatives
  • 10.4.6 SINGLERA GENOMICS
    • 10.4.6.1 Company overview
    • 10.4.6.2 Financial performance
    • 10.4.6.3 Product benchmarking
    • 10.4.6.4 Strategic initiatives
  • 10.4.7 GENECAST
    • 10.4.7.1 Company overview
    • 10.4.7.2 Financial performance
    • 10.4.7.3 Product benchmarking
    • 10.4.7.4 Strategic initiatives
  • 10.4.8 FOUNDATION MEDICINE INC.
    • 10.4.8.1 Company overview
    • 10.4.8.2 Financial performance
    • 10.4.8.3 Product benchmarking
    • 10.4.8.4 Strategic initiatives
  • 10.4.9 23ANDME, INC.
    • 10.4.9.1 Company overview
    • 10.4.9.2 Financial performance
    • 10.4.9.3 Product benchmarking
    • 10.4.9.4 Strategic initiatives
  • 10.4.10 FREENOME
    • 10.4.10.1 Company overview
    • 10.4.10.2 Financial performance
    • 10.4.10.3 Product benchmarking
    • 10.4.10.4 Strategic initiatives
  • 10.4.11 MYRIAD GENETICS
    • 10.4.11.1 Company overview
    • 10.4.11.2 Financial performance
    • 10.4.11.3 Product benchmarking
    • 10.4.11.4 Strategic initiatives
  • 10.4.12 CEPHEID (DANAHER)
    • 10.4.12.1 Company overview
    • 10.4.12.2 Financial performance
    • 10.4.12.3 Product benchmarking
    • 10.4.12.4 Strategic initiatives
  • 10.4.13 BIORAD LABORATORIES INC.
    • 10.4.13.1 Company overview
    • 10.4.13.2 Financial performance
    • 10.4.13.3 Product benchmarking
    • 10.4.13.4 Strategic initiatives
  • 10.4.14 BGI GENOMICS INC.
    • 10.4.14.1 Company overview
    • 10.4.14.2 Financial performance
    • 10.4.14.3 Product benchmarking
    • 10.4.14.4 Strategic initiatives
  • 10.4.15 INVITAE CORPORATION
    • 10.4.15.1 Company overview
    • 10.4.15.2 Financial performance
    • 10.4.15.3 Product benchmarking
    • 10.4.15.4 Strategic initiatives
  • 10.4.16 CENTOGENE N.V.
    • 10.4.16.1 Company overview
    • 10.4.16.2 Financial performance
    • 10.4.16.3 Product benchmarking
    • 10.4.16.4 Strategic initiatives
  • 10.4.17 GENE DX, LLC (SEMA4)
    • 10.4.17.1 Company overview
    • 10.4.17.2 Financial performance
    • 10.4.17.3 Product benchmarking
    • 10.4.17.4 Strategic initiatives